← European Medicine Shortage Tracker · all medicines

Ondansetron shortage — availability across Europe

Name: European Medicine Shortage Tracker dataset
Creator: MobiDoctor
License: https://creativecommons.org/licenses/by/4.0/

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED

Dr. Chrysoula I. Liakou MD, PhD

Internal Medicine Specialist
Cancer Immunology Researcher

Reviewed 30 July 2026 · next review due 30 January 2027

Ondansetron currently has availability issues reported in 5 European registers: Spain, France, Ireland, Italy, Sweden.

Shortage ATC — · also listed as: ONDANSETRON · ONDANSETRÓN · ondansétron · ONDANSETRONE · ondansetronhydrokloriddihydrat · data refreshed 9 September 2026

Key facts

As of 9 September 2026, Ondansetron has active availability issues in 5 of 9 tracked European registers.
Registers reporting issues: Spain, France, Ireland, Italy, Sweden.
Latest expected-resolution date on file: 2027-01-31.
Longest-running open report: since 2023-07-12 (38 months, Spain).
Data source: 5 official medicines-agency registers, refreshed daily.

As of 9 September 2026, 5 of the 9 tracked registers list current availability issues for Ondansetron, covering 14 affected product presentations. The longest-running open report was filed in Spain on 2023-07-12 and has now been open for about 38 months. Where agencies state a cause, unexpectedly high demand lead with 3 of the 5 stated-cause reports, followed by manufacturing problems with 2. The furthest expected-resolution date currently on file is 2027-01-31; the earliest is 2026-09-14. Notably, 2 reports have already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Spain reported first (2023-07-12), with Italy following roughly 30 months later — a pattern typical of supply problems cascading between national markets. Registers in Spain, Ireland, Italy, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

Where	Status & products	Since	Expected end	Reason / alternatives	Source
🇪🇸 Spain	Shortage ONDANSETRON B. BRAUN 2 mg/ml SOLUCION INYECTABLE EFG , 5 ampollas de 2 ml + 2 more products ONDANSETRÓN SERRACLINICS 2 MG/ML SOLUCIÓN INYECTABLE EFG, 50 ampollas de 2 ml ONDANSETRÓN SERRACLINICS 2 MG/ML SOLUCIÓN INYECTABLE EFG, 50 ampollas de 4 ml	2023-07-12	—	Existen otros medicamentos con el mismo principio activo y misma vía. Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.	register ↗
🇫🇷 France	Limited availability Zophren 2 mg/ml, solution injectable en ampoule (IV)	—	—	Hépato-gastroentérologie	register ↗
🇮🇪 Ireland	Shortage Ondansetron 4 mg film-coated tablets + 1 more products Ondansetron 8 mg film-coated tablets	2025-11-23	2026-09-14	Manufacturing delay (Multiple countries) Alternatives: Alternative(s) available — see the national register.	register ↗
🇮🇹 Italy	Shortage ONDANSETRON DOC + 2 more products ONDANSETRONE MYLAN GENERICS ONDANSETRONE MYLAN GENERICS	2026-01-22	—	Elevata richiesta Alternatives: AIFA: import of a foreign equivalent can be authorised.	register ↗
🇸🇪 Sweden	Shortage Ondansetron 2care4 4 mg Munsönderfallande tablett + 4 more products Ondansetron Aurobindo 4 mg Filmdragerad tablett Ondansetron EQL Pharma 8 mg Filmdragerad tablett Ondansetron Ebb 4 mg Munsönderfallande tablett Ondansetron Teva 4 mg Filmdragerad tablett	2024-08-19	2027-01-31	— Alternatives: Alternative(s) available — see the national register.	register ↗

New register reports per month

Full report history (14 register entries)

Every individual register entry for Ondansetron in the tracked sources, newest first — including resolved and discontinued reports.

Reg.	Product	Status	Reported	Expected end	Stated reason
🇸🇪 SE	Ondansetron Aurobindo 4 mg Filmdragerad tablett	Shortage	2026-07-06	2026-08-07
🇸🇪 SE	Ondansetron Teva 4 mg Filmdragerad tablett	Shortage	2026-06-29	2026-09-30
🇸🇪 SE	Ondansetron 2care4 4 mg Munsönderfallande tablett	Shortage	2026-04-20	2026-10-31
🇮🇹 IT	ONDANSETRONE MYLAN GENERICS	Shortage	2026-04-15	—	Elevata richiesta
🇮🇪 IE	Ondansetron 4 mg film-coated tablets	Shortage	2026-04-10	2026-07-30	Manufacturing delay (Multiple countries)
🇮🇹 IT	ONDANSETRON DOC	Shortage	2026-02-27	—	Elevata richiesta
🇮🇹 IT	ONDANSETRONE MYLAN GENERICS	Shortage	2026-01-22	—	Elevata richiesta
🇮🇪 IE	Ondansetron 8 mg film-coated tablets	Shortage	2025-11-23	2026-09-14	Manufacturing delay (Global)
🇸🇪 SE	Ondansetron Ebb 4 mg Munsönderfallande tablett	Shortage	2025-10-23	2026-09-15
🇪🇸 ES	ONDANSETRON B. BRAUN 2 mg/ml SOLUCION INYECTABLE EFG , 5 ampollas de 2	Shortage	2025-10-14	—	Existen otros medicamentos con el mismo principio activo y m
🇸🇪 SE	Ondansetron EQL Pharma 8 mg Filmdragerad tablett	Shortage	2024-08-19	2027-01-31
🇪🇸 ES	ONDANSETRÓN SERRACLINICS 2 MG/ML SOLUCIÓN INYECTABLE EFG, 50 ampollas	Shortage	2023-11-21	—	Existen otros medicamentos con el mismo principio activo y m
🇪🇸 ES	ONDANSETRÓN SERRACLINICS 2 MG/ML SOLUCIÓN INYECTABLE EFG, 50 ampollas	Shortage	2023-07-12	—	Existen otros medicamentos con el mismo principio activo y m
🇫🇷 FR	Zophren 2 mg/ml, solution injectable en ampoule (IV)	Limited availability	—	—	Hépato-gastroentérologie

Frequently asked

Is Ondansetron currently in shortage in Europe?

Yes. As of 9 September 2026, availability issues are reported in: Spain, France, Ireland, Italy, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Ondansetron shortage expected to end?

Agency prognoses on file range from 2026-09-14 to 2027-01-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Ondansetron?

13 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Ondansetron availability data come from?

Directly from the official medicines-agency registers that list Ondansetron: AEMPS CIMA (Spain), ANSM (France), HPRA (Ireland), AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Ondansetron — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/ondansetron/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Ondansetron availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/ondansetron/">Ondansetron shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>

Cite: “Ondansetron: availability status across 5 European registers — European Medicine Shortage Tracker (MobiDoctor), 9 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.